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Abstract 
Background: An effective antibiotic stewardship program relies on the measurement of appropriate antibiotic use, 
on which there is a lack of consensus. We aimed to develop a set of key quality indicators (QIs) for nationwide point 
surveillance in the Republic of Korea.
Methods: A systematic literature search of PubMed, EMBASE, and Cochrane Library (publications until 20th Novem‑
ber 2019) was conducted. Potential key QIs were retrieved from the search and then evaluated by a multidisciplinary 
expert panel using a RAND‑modified Delphi procedure comprising two online surveys and a face‑to‑face meeting.
Results: The 23 potential key QIs identified from 21 studies were submitted to 25 multidisciplinary expert panels, 
and 17 key QIs were retained, with a high level of agreement (13 QIs for inpatients, 7 for outpatients, and 3 for surgical 
prophylaxis). After adding up the importance score and applicability, six key QIs [6 QIs (Q 1–6) for inpatients and 3 (Q 
1, 2, and 5) for outpatients] were selected. (1) Prescribe empirical antibiotic therapy according to guideline, (2) change 
empirical antibiotics to pathogen‑directed therapy, (3) obtain culture samples from suspected infection sites, (4) 
obtain two blood cultures, (5) adapt antibiotic dosage to renal function, and (6) document antibiotic plan. In surgical 
prophylaxis, the QIs to prescribe antibiotics according to the guideline and initiate antibiotic therapy 1 h before inci‑
sion were selected.
Conclusions: We identified key QIs to measure the appropriateness of antibiotic therapy to identify targets for 
improvement and to evaluate the effects of antibiotic stewardship intervention.
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Background
The increased use of broad-spectrum antibiotics is 
closely related to antimicrobial resistance [1, 2]. There-
fore, a need to assess appropriate antibiotic use has 
been emphasized [3] and includes various steps, such 
as diagnosis, empirical therapy, dosing, de-escalation, 
and therapy duration [4]. Moreover, the appropriateness 
can change with the definition of appropriate antibiotic 
use [5]. Therefore, researchers have attempted to evalu-
ate antibiotic use’s appropriateness with standard crite-
ria by using quality indicators (QIs) developed through 
expert consensus. In 2018, the European Surveillance 
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of Antimicrobial Consumption group developed QIs 
to evaluate appropriate antibiotic use in inpatients and 
outpatients in Europe [6, 7]. In Australia, surveillance 
of appropriate antibiotic use has been conducted since 
2011. Key indicators have been developed [8]; results of 
appropriate antibiotic use have been generated through 
national surveillance every year using the key indica-
tors. Nonetheless, it is important to evaluate appro-
priate antibiotic use with standard criteria, which can 
then be directly compared between medical institu-
tions and provide feedback to generate suggestions to 
improve the goals of national antibiotic stewardship. 
The QIs are diverse, and some indicators are difficult to 
apply and; therefore, it is necessary to select appropri-
ate QIs through consensus on the antibiotic prescription 
situation (location), infectious disease, and the type of 
antibiotics.
In the Republic of Korea (ROK), point surveillance of 
appropriate antibiotic use was conducted for 20 medical 
institutions in 2018, and the appropriateness was deter-
mined based on expert opinion [9]. This experience gen-
erated a need to evaluate appropriate antibiotic use based 
on specific standards. This study aimed to select potential 
QIs for appropriate antibiotic use through a systematic 
literature search and determine the key QIs necessary 
and important in the ROK through expert consensus. 
In addition, the developed key QIs will be used in future 
nationwide point surveillance of appropriate antibiotic 
use.
Methods
We used a four-step RAND-modified Delphi method 
to develop a set of QIs to measure the appropriateness 
of antimicrobial use in adult and hospitalized pediat-
ric patients, outpatients, or patients receiving surgical 
prophylaxis [10, 11]. Figure  1 presents an overview of 
the RAND-modified Delphi procedure, which included 
a comprehensive literature review to develop a list of 
candidate key QIs, two rounds of an online survey, and 
a face-to-face meeting with the panelists. The consensus 
procedure combined the individual opinions of multidis-
ciplinary expert panels. All the panel members consented 
to participate in the study and were aware that their 
answers would be used for research.
Systematic search for generating key QIs
We performed a systematic search using a protocol 
designed by two independent medical librarians (D.W.S 
and M.L). We screened the literature using databases of 
PubMed, EMBASE, and Cochrane Library for papers 
published up to 20th November 2019. The search strat-
egy is shown in Additioinal file 1: Fig. S1 and was directed 
towards identifying evidence-based QIs for antibiotic 
use (e.g., literature review or evidence-based guideline). 
Papers written in English and discussed using systemi-
cally administered antibiotic drugs in inpatients, outpa-
tients, and surgical prophylaxis were included, except for 
case reports. This study aimed to develop key QIs useful 
to assess the antibiotic use appropriateness in treating 
all bacterial infections and surgical prophylaxis. There-
fore, we excluded antiviral, antifungal, antiparasitic, or 
antituberculosis drugs. Using EndNote software (version 
X7.1, 2020 Clarivate), two researchers (B.K. and S.Y.P.) 
independently examined all titles and abstracts to select 
papers that described QIs. Any disagreement on the 
inclusion or exclusion of studies was resolved through 
discussion with a third author (S.M.). If no abstract was 
available or there was a lack of information for the eli-
gibility assessment, papers were selected for full-text 
screening. The inclusion/exclusion criteria evaluation 
for full-text screening was performed by two researchers 
(B.K. and S.Y.P.).
Selection of potential key QIs
Data on potential QIs were extracted by four researchers 
(B.K., M.J.L., S.Y.P., and S.M.). The QIs were excluded if 
they were: not concerned with antibiotic use for a spe-
cific group of patients, non-normative, or developed for 
each institution and not for patients. The extracted QIs 
were then clustered into different non-overlapping logi-
cal themes based on the definition of responsible use. 
When a QI could be allocated to more than one theme, 
the predominant theme was chosen based on consensus 
between two authors (B.K. and S.Y.P.). Duplicates were 
removed, and the QIs were rephrased as a recommenda-
tion. The clustering, aggregating, and rephrasing steps 
were undertaken consensually among four authors (B.K., 
M.J.L., S.Y.P., and S.M.).
First online survey
We emailed invitations to different specialists for their 
participation in 25 expert panels. The panel of doctors 
comprised experts working at university-affiliated hos-
pitals in the ROK. During panel selection, we aimed to 
select experts representative and responsible for antibi-
otic prescriptions. The panel comprised infectious dis-
ease specialists (n = 13), laboratory medicine doctors 
(n = 3), pediatric infectious diseases specialists (n = 2), 
urologists (n = 2), otorhinolaryngologist (n = 1), gas-
troenterologist (n = 1), pulmonologist (n = 1), general 
surgeon (n = 1), and researchers of the National Evi-
dence-Based Healthcare Collaborating Agency (n = 1) 
(Additioinal file 3: Table S2). To rate the degree to which 
the potential QI described appropriate antibiotic use, 
a Likert scale, ranging from 1 (‘definetly inappropriate 
care’) to 7 (‘definitely appropriate care’), was used. The 
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panelists could rephrase the potential indicator and could 
even add new items. A consensus was defined as the 
case wherein ≥ 70% of the scores were in the top quartile 
(scores 6 and 7); similarly, scores with < 70% agreement 
were defined as disagreement. QIs with a median score of 
6 or 7 were accepted if there was agreement. If there was 
disagreement and the median score was ≤ 5, the QI was 
rejected. Thus, QIs with a median score of 6 and 7 with 
disagreement were discussed during the expert panel 
meeting. In addition, we graded each QI using a Likert 
scale score, ranging from 1 to 7, as relevant to inpatient 
care, outpatient care, or surgical prophylaxis. If the score 
was 6 or 7, we considered it to be an appropriate QI.
Expert panel meeting
All panel members were invited to a face-to-face panel 
meeting. Before the meeting, all participants received 
a personal feedback report with the results of the first 
online questionnaire. The agenda of the panel meeting 
was to present the results of the first round of the survey 
and to discuss the QIs with a median score of 6 or 7 that 
had inadequate consensus. These QIs were accepted if 
at least 70% of the experts concurred. In addition, newly 
added potential QIs were discussed, and the accepted QIs 
with comments from the experts were rephrased base on 
consensus.
Second online survey
A second questionnaire that included all the selected 
and rephrased QIs were sent with a personal feedback 
report (providing the results of the previous two steps of 
the consensus procedure) to all participating panelists. 
The panelists were asked to select from the following 
three answers: ‘agree,’ ‘disagree,’ and ‘cannot assess.’ The 
Fig. 1 Flowchart of the study procedures
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rephrased indicators were accepted if at least 70% of 
the experts agreed with the new formulation. Further-
more, we asked the panelists to consider the importance 
of potential QIs that could be used as key indicators 
for antibiotic use in the ROK, with a Likert scale score 
from 1 ‘less important’ to 5 ‘highest importance’. If the 
QIs could be evaluated in point surveillance, we consid-
ered them applicable. This was finally confirmed by four 
researchers (B.K., M.J.L., S.Y.P., and S.M.). We excluded 
QIs with durations in which appropriateness was difficult 
to evaluate by point surveillance.
Results
Literature search and selection of potential key QIs
The systematic literature search identified 4293 arti-
cles, of which only 21 articles were finally selected after 
screening against the inclusion/exclusion criteria (Addi-
tioinal file 2: Table S1) [6, 7, 12–29]. From these 21 arti-
cles, we initially derived 192 QIs. After duplications were 
removed and the quantitative or institution-level QIs 
were excluded, 23 QIs were finally included (Table  1). 
This list of 23 QIs was presented to the panelists in the 
first round of the consensus procedure.
First online survey
The first online round of the survey was conducted from 
27th December 2019 to 8th January 2020. In total, 24 
(96%, 24/25) panelists responded to the first online ques-
tionnaire. Among the 23 potential QIs, 13 QIs (57%) 
were accepted, 6 (26%) were discussed, and 4 (17%) were 
rejected (Table  2). Three additional QIs were suggested 
from the results of the online survey: (1) dose adjust-
ment of surgical antibiotic prophylaxis according to body 
weight, (2) Percentage of blood cultures among those 
who received systemic antibiotic use, and (3) empirical 
antibiotic therapy should be prescribed in community-
acquired or healthcare-associated infections. The appli-
cation of QIs was appropriate in hospitalized patients 
(n = 17), outpatients (n = 9), and surgical prophylaxis 
(n = 6).
Table 1 Final lists of potential key quality indicators
These potential quality indicators are final version after Delphi procedure
QI quality indicator
Nos. Potential key quality indicators
QI 1 Empirical systemic antibiotic therapy should be prescribed according to the institutional, national, or international guideline
QI 2 Before starting systemic antibiotic therapy, at least two sets of blood cultures should be taken
QI 3 When starting systematic antibiotic therapy, specimens for culture from suspected sites of infection should be taken as soon as possible, prefer‑
ably before antibiotics are started
QI 4 An antibiotic plan should be documented in the case notes at the start of systemic antibiotic therapy
QI 5 Systemic antibiotic therapy should be switched from i.v. to oral antibiotic therapy within 48–72 h on the basis of the clinical condition and when 
oral treatment is adequate
QI 6 Empirical antibiotic therapy should be changed to pathogen‑directed therapy if culture results become available
QI 7 Dose and dosing interval of systemic antibiotic therapy should be adapted to renal function
QI 8 Therapeutic drug monitoring should be performed when the therapy duration is > 3 days for aminoglycosides and > 5 days for vancomycin
QI 9 Empirical antibiotic therapy for presumed bacterial infection should be discontinued based on the lack of clinical and/or microbiological evi‑
dence of infection. The maximum duration of empirical systemic antibiotic treatment should be 7 days
QI 10 Surgical prophylaxis antibiotic therapy should be prescribed according to guideline
QI 11 Surgical prophylaxis antibiotic therapy should be initiated within 1 h before incision
QI 12 Surgical prophylaxis antibiotic therapy should be discontinued within 1 day
QI 13 Antibiotic therapy in adult patients with sepsis should be started intravenously
QI 14 Contraindications (history of allergy, anaphylaxis, or toxicity) should be taken into account when prescribing antibiotics
QI 15 Acute upper respiratory infections and bronchitis should not be treated with antibiotics within the first 3 days, unless there is documented 
indication for treatment
QI 16 Antibiotics should be prescribed within appropriate cost
QI 17 Antibiotics should be prescribed in appropriate duration
QI 18 Antibiotics with anaerobic activity combination of two or more antimicrobials
QI 19 Outpatients with acute tonsillitis/pharyngitis should undergo a group A streptococcal diagnostic test to decide whether or not they should 
receive antibiotics
QI 20 Follow up cultures 4–7 days after initial blood culture positivity (bloodstream infection due to Staphylococcus aureus and fungi)
QI 21 Documented significant single‑organism bacteriuria
QI 22 Perform ID specialist bedside consultation in hospitalized patient
QI 23 Appropriate pharmacokinetics
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Expert panel meeting
The face-to-face panel meeting was held on 10th Janu-
ary 2020, and 16 (64%, 16/25) panelists participated 
in this meeting. Among the six potential QIs from the 
first online questionnaire round discussed, three were 
conclusively accepted, and three were rejected. QI 10 
was merged with QI 1. Among the three suggested QIs 
from the first survey, one QI (dose adjustment of surgi-
cal antibiotic prophylaxis according to body weight) was 
accepted. The other two QIs (percentage of blood culture 
among those with systemic antibiotic use and empiri-
cal antibiotic therapy should be prescribed in commu-
nity-acquired or healthcare-associated infections) were 
merged with QI 1 and QI 2, respectively (Table 2).
Second online survey
A total of 17 potential QIs (16 pre-existing QIs, and one 
new QI was added) were included in the second online 
questionnaire. Twenty-three (92%, 23/25) panelists par-
ticipated in this survey. All potential QIs were accepted 
(Table 2). The ranking of the final selected key QIs and 
applicability in the point surveillance study is shown in 
Table 3 (inpatients and out-patients) and Table 4 (surgi-
cal prophylaxis). Based on the sum of the importance 
score and applicability, six key QIs for hospitalized 
patients and three (following number 1–3) for outpa-
tients were finally selected. (1) Prescribe empirical anti-
biotic therapy according to the guideline, (2) change 
empirical antibiotic to pathogen-directed therapy, (3) 
obtain culture samples from suspected sites of infec-
tion, (4) take two blood cultures, (5) adapt antibiotic 
dosage to renal function, and (6) document the antibi-
otic plan. Concerning surgical prophylaxis, the recom-
mendations to prescribe according to the guideline and 
initiate antibiotics 1  h before the incision were finally 
selected.
Table 3 Ranking of final selected key quality indicators for admitted and outpatients and applicability in point surveillance study
QI quality indicator
Quality indicators Inpatients Outpatients
Ranking Total score Applicability Ranking Total score Applicability
QI 1. Empirical systemic antibiotic therapy should be prescribed 
according to the institutional, national, or international guideline
1 114 Yes 1 114 Yes
QI 6. Empirical antibiotic therapy should be changed to pathogen‑
directed therapy if culture results become available
2 109 Yes 2 109 Yes
QI 3. When starting systematic antibiotic therapy, specimens for 
culture from suspected sites of infection should be taken as soon as 
possible, preferably before antibiotics are started
3 103 Yes
QI 2. Before starting systemic antibiotic therapy, at least two sets of 
blood cultures should be taken
4 100 Yes
QI 7. Dose and dosing interval of systemic antibiotic therapy should be 
adapted to renal function
5 96 Yes 3 96 Yes
QI 17. Antibiotics should be prescribed in appropriate duration 6 92 No 4 92 No
QI 4. An antibiotic plan should be documented in the case notes at 
the start of systemic antibiotic therapy
7 89 Yes
QI 9. Empirical antibiotic therapy for presumed bacterial infection 
should be discontinued based on the lack of clinical and/or micro‑
biological evidence of infection. The maximum duration of empirical 
systemic antibiotic treatment should be 7 days
8 88 No 5 88 No
QI 14. Contraindications (history of allergy, anaphylaxis, or toxicity) 
should be taken into account when prescribing antibiotics
9 87 No 6 87 No
QI 18. Antibiotics with anaerobic activity combination of two or more 
antimicrobials
10 84 No
QI 5. Systemic antibiotic therapy should be switched from i.v. to oral 
antibiotic therapy within 48–72 h on the basis of the clinical condi‑
tion and when oral treatment is adequate
11 82 No
QI 20. Follow up cultures 4–7 days after initial blood culture positivity 
(bloodstream infection due to Staphylococcus aureus and fungi)
12 69 No
QI 8. Therapeutic drug monitoring should be performed when the 
therapy duration is > 3 days for aminoglycosides and > 5 days for 
vancomycin
13 52 No 7 84 No
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Discussion
We selected key QIs from among the potential QIs 
extracted in a systematic literature search followed by 
a RAND-modified Delphi survey procedure. These key 
QIs are intended to be universally applicable, regard-
less of the type of infectious disease, location, or situa-
tion of antibiotic use. This study is practical in that the 
key QIs can be applied in all antibiotic use situations, 
including inpatients, outpatients, and surgical prophy-
laxis, and were selected through an expert panel con-
sensus with ranking for importance and consideration 
of applicability in point surveillance. The selected key 
QIs for hospitalized patients and outpatients should 
be applied in a point surveillance study for antibiotic 
appropriateness in 75 hospitals in the ROK in 2020.
Finally, selected Key QIs were included in several 
steps of antibiotic prescription, such as diagnosis (QI 
2, 3, and 4), empiric therapy (QI 1), dosing (QI 7), and 
definite therapy (QI 6). QIs related to therapy duration 
were not selected, although it got a considerably high 
score on the importance scale among experts. Therapy 
duration is increasingly an important focus area for 
antimicrobial stewardship activity. However, expected 
applicability was below 10% based on previous studies 
[9, 13, 22]. Therefore, we excluded these QIs in the final 
selection. If point surveillance or applicability is not 
considered, the QIs selected in the second online sur-
vey can be used by an antibiotic stewardship team or a 
researcher, depending on the surveillance purpose.
Assessing antibiotic use’s appropriateness can be 
divided mainly into evaluating the entire antibiotic 
options and evaluating certain antibiotics or diseases 
[30]. In addition, the scope of assessment varies greatly 
depending on the study, from empirical antibiotics to 
therapeutic antibiotics, dosing, narrow-spectrum anti-
biotics, duration of treatment, and presence of medical 
records [4]. Moreover, the methods of evaluation can be 
divided into judgments based on guidelines, judgment 
by experts, and judgments using QIs [5]. Therefore, the 
scope of evaluation and the criteria for assessing appro-
priate antibiotic use should be determined by research-
ers according to the surveillance purpose. Because of 
the increasing need for antibiotic stewardship, national 
surveillance of appropriate antibiotic use commenced 
in 2018 in the ROK. To establish a national target of 
antibiotic stewardship, we included the entire gamut of 
antibiotic use, regardless of infectious disease type.
To date, the most widely used QIs are 11 indicators 
that were selected by van den Bosch et  al. [14] in the 
Netherlands. These QIs were selected from 1574 studies 
through a literature review. The RAND-modified Del-
phi procedure was used to propose the final 11 QIs; of 
these, nine were proposed at the patient level and two at 
the institutional level [14]. Those 11 QIs were applied to 
1890 inpatients in 22 hospitals in the Netherlands in 2011 
and 2012. The applicability of three QIs (therapeutic drug 
monitoring, adapting antibiotics to renal function, dis-
continuation of empirical therapy in case of a lack of clin-
ical and/or microbiological evidence of infection) were 
less than 10% [13]. In this study, the nine potential key 
QIs of patient-level by van den Bosch et al. were merged 
and finally selected after obtaining consensus. Consider-
ing their applicability in the point surveillance study, we 
finally excluded key QIs on duration, such as “appropri-
ate duration” and “discontinue antibiotic therapy if an 
infection is not confirmed.” The “adapted dose and dosing 
interval of antibiotics to renal function” QI was expected 
to have low applicability. However, it was finally accepted 
because this key QI can be evaluated by point surveil-
lance, and the panel considered it important.
The advantage of QIs over expert judgment is that the 
evaluation results of each QI show the areas that need 
improvement. In addition, comparisons with other medi-
cal institutions show whether the specified institution 
needs improvement. Another advantage is that the same 
criteria can be applied every year to determine whether 
one’s institution has improved. In Australia, four key 
QIs (documentation of indication, documentation of 
review or stop date, surgical prophylaxis for > 24  h. and 
noncompliance with guidelines) and inappropriate anti-
biotic prescription rates are presented annually along 
with the target levels [8]. Based on the collected data, 
the researchers could identify priority areas for tar-
geted quality improvement initiatives directed toward 
Table 4 Ranking of final selected key quality indicators for surgical prophylaxis and applicability in point surveillance study
QI quality indicator
Ranking Quality indicators Total score Applicability
1 QI 10. Surgical prophylaxis antibiotic therapy should be prescribed according to guideline 113 Yes
2 QI 11. Surgical prophylaxis antibiotic therapy should be initiated within 1 h before incision 109 Yes
3 QI 12. Surgical prophylaxis antibiotic therapy should be discontinued within 1 day 103 No
4 QI 17. Antibiotics should be prescribed in appropriate duration 92 No
5 QI 24. Dose of surgical prophylaxis antibiotics should be adjusted according to body weight 58 No
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antimicrobial prescribing patterns. In comparison, judg-
ments may differ among experts, and it is difficult to 
ascertain the aspects required for improvement. Thus, 
efforts to select the key QIs agreed upon by each country 
or institution are a necessary task in the future.
A limitation of this study is that members of the expert 
panel were only Koreans, and none was with pharmacy 
expertise. The QIs would be difficult to apply in other 
countries with different medical environments from the 
ROK. Pharmacy expertise was suggested as a core ele-
ment of hospital antibiotic stewardship programs; how-
ever, the current antimicrobial stewardship program is 
mainly performed by infectious diseases specialists in 
the ROK [31, 32]. Second, the literature search scope was 
restricted to English-only papers and limited to only a lit-
erature database, without a website search. Therefore, we 
may have missed important papers in other languages. 
However, English is considered a major global medium in 
the scientific literature directed toward a global audience.
Conclusions
In this study, key QIs that can be applied to hospital-
ized patients, outpatients, and surgical prophylaxis were 
selected in the ROK. Not only will these key QIs be 
applied in national point surveillance initiatives in the 
ROK in 2020, but also other users will be able to use the 
QIs for antibiotic stewardship programs or in educational 
materials for appropriate antibiotic use. Evaluators will 
be able to prioritize antibiotic use based on the impor-
tant indicators identified in this study. It is expected that 
the application of key QIs will complement and apply the 
advantages and limitations of the evaluation indicators 
experienced by the actual evaluators and researchers.
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